ArticleACS medicinal chemistry letters2020

Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 Activity.

Jean-Marc M Grandjean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.